Health Canada reviewing stop-smoking drug Champix (varenicline tartrate) and potential risk of heart problems in patients with heart disease

Health Canada is informing Canadians of an ongoing review of the smoking-cessation aid Champix (the brand name for the prescription drug varenicline tartrate) and the possibility of a slightly increased risk of heart-related side effects in patients who have cardiovascular disease.  For more information click here